Thromb Haemost 1999; 81(06): 989
DOI: 10.1055/s-0037-1614611
Letters to the Editor
Schattauer GmbH

Factor V Leiden Mutation in the Argentinian Population

M. Hepner
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
A. Roldan
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
G. Pieroni
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
J. P. Frontroth
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
R. M. Serviddio
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
A. Feliú Torres
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
G. Sciuccati
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
,
M. Bonduel
1   From the Dept. of Haematology/Oncology, Hospital de Pediatria, Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina
› Author Affiliations
Further Information

Publication History

Received 27 August 1998

Accepted 23 February 1999

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1993; 330: 517-22.
  • 2 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
  • 3 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
  • 4 Fujimura H, Kambayashi J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 1996; 74: 1381-2.
  • 5 Dahlbäck B. Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997; 78: 483-8.
  • 6 Hepner M, Roldán A, Pieroni G, Frontroth J, Serviddio RM, Feliú Torres A, Sciuccati G, Bonduel M. Frequency of factor V Arg506 to Gln mutation (FV Leiden) and activated protein C resistance in blood donors in Argentina. A preliminary study. Thromb Haemost 1997; (Suppl. 01) 919a (abstract)
  • 7 Kawasaki ES. Sample preparation from blood, cells and other fluids. In PCR protocols Innis MA, Gelfand DH, Sninsky JJ, White TJ. eds San Diego: Academic Press; 1990: 146.
  • 8 Schröder W, Koesling M, Wulff K, Wehnert M, Herrmann FH. Large-scale screening for factor V Leiden mutation in a north-eastern German population. Haemostasis 1996; 26: 233-6.